Immunology and Breast Cancer

Every disease causes an immune response, which is the first line of defence against the spread of any malignancy. In the case of breast cancer, a connection exists between the immune system and the development of tumours. The environment around the tumour contains a variety of immune cells that may be able to stop the spread of breast cancer. These immune cells may be modulated by therapies used to treat breast cancer. Antigen-specific immunoglobulin is secreted by B lymphocytes, and it may have anticancer characteristics. Breast cancer patients have more B lymphocytes in their bone marrow than healthy individuals do, which can be an important factor in the therapy of breast cancer.

  • Immunogenicity of Breast Cancer
  • Anti-PD-1/PD-L1 Agents in Breast Cancer

Related Conference of Immunology and Breast Cancer

June 12-13, 2023

13th World Congress on Breast Cancer Research & Therapies

Melbourne, Australia
June 19-20, 2023

11th World Summit on Cancer Science and Oncology

Vienna, Austria
July 19-20, 2023

42nd World Cancer Conference

Zurich, Switzerland
July 24-25, 2023

10th World Congress on Epigenetics and Chromosome

Amsterdam, Netherlands
July 27-28, 2023

6th International Conference on Women Oncology

Vancouver, Canada
August 07-08, 2023

4th World Congress on Breast Cancer

Paris, France
August 23-24, 2023

23rd World Congress on Cancer and Diagnostics

Toronto, Canada
September 07-08, 2023

7th Global Meeting on Oncology and Radiology

Paris, France
September 21-22, 2023

15th Annual Conference on Cancer Research

Kualalumpur, Malaysia
October 04-05, 2023

8th Global Summit on Cancer Science and Oncology

Barcelona, Spain
November 08-09, 2023

International Conference on Cancer Biology and Therapeutics

Budapest, Hungary
November 15-16, 2023

36th Conference on Preventive Oncology and Diagnostic Cancer

Edinburgh, Scotland

Immunology and Breast Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in